Lesson plan
Retro screening
Retro screening, also known as reverse screening (RS), is a computational approach for identifying potential protein targets, unintended targets, and off-target interactions of a bioactive or therapeutic molecule.. It proceeds in the opposite direction to the so-called virtual screening (VS). In VS, the goal is to use a protein target to identify a high-affinity ligand from a search library typically containing hundreds of thousands of small molecules. In contrast, RS starts with a known drug or bioactive molecule and screens it against a panel or database of potential protein targets, using experimentally determined and/or computationally predicted protein structures(obtained from both experimental and modeling techniques). Accordingly, predicted or experimentally confirmed interactions of the drug with proteins beyond its intended target can provide information about its selectivity, potential off-target effects, and possible adverse effects. RS can provide an additional computational layer for target identification, off-target prediction, drug repurposing, and assessment of potential adverse effects in drug discovery.
Article summary
Retro screening, also known as reverse screening (RS), is a computational approach for identifying potential protein targets, unintended targets, and off-target interactions of a bioactive or therapeutic molecule.. It proceeds in the opposite direction to the so-called virtual screening (VS). In VS, the goal is to use a protein target to identify a high-affinity ligand from a search library typically containing hundreds of thousands of small molecules. In contrast, RS starts with a known drug or bioactive molecule and screens it against a panel or database of potential protein targets, using experimentally determined and/or computationally predicted protein structures(obtained from both experimental and modeling techniques). Accordingly, predicted or experimentally confirmed interactions of the drug with proteins beyond its intended target can provide information about its selectivity, potential off-target effects, and possible adverse effects. RS can provide an additional computational layer for target identification, off-target prediction, drug repurposing, and assessment of potential adverse effects in drug discovery.
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.